News | September 02, 2023
USFDA delegation visits Amneal Pharmaceutical facility in Matoda
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
Propranolol LA is a generic equivalent of Inderal LA
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
Subscribe To Our Newsletter & Stay Updated
